Jay Arvind Bhanushali Acquires Stake in Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics Ltd · Acquisition/ Disposal of Shares · 05 Sept 2026, 5:22 pm
Jay Arvind Bhanushali Acquires Stake in Aspira Pathlab & Diagnostics Promoter Jay Arvind Bhanushali acquired 623 equity shares (0.0060% stake) of Aspira Pathlab & Diagnostics Ltd through open market purchases on 2nd Sep'26. Following the transaction, his holding marginally increased from 7,45,754 shares (7.25%) to 7,46,377 shares (7.25%) of the total equity base. The company's total voting capital remains unchanged at ₹10,29,30,000, comprising 1,02,93,000 equity shares of ₹10 each.
Original exchange filing (PDF)
More announcements from Aspira Pathlab & Diagnostics Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali · 14 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali · 14 Nov 2026
- Enclosed herewith Financial Result for the Half Year ended 30th September 2026 · 06 Nov 2026
- Enclosed herewith Board Meeting Outcomes dated 6th November 2026 · 06 Nov 2026
- Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Un-audited Financial .... · 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali · 01 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali · 28 Sept 2026
- Disclosure of Voting Results of 53rd Annual General Meeting along with the Scrutinizer Report · 26 Sept 2026
